Korea Develops World’s First “Brainwave” Healthcare Technology

New technology, ‘Mr. Brain ‘identifies driver condition using brain waves

After 3 years of R&D, Hyundai Mobis, based in South Korea, has finally succeeded in developing M.Brain, a new health technology based on the measurement of brain waves.

This achievement is the subject of great attention for the application for the first time of this brainwave measurement technology to the automotive industry. Among other biosignals, measuring brain waves is known to be one of the most advanced and difficult technologies to use.

M.Brain measures the condition of the driver in real time by detecting brain waves around the ears using the headphones sensors worn. The key is the software technology that analyzes and determines the brainwave data. Hyundai Mobis has engaged in R&D and even adopted machine learning to interpret brain wave signals.

M.Brain can also be interworked with a smartphone app and warn that the driver is losing attention. Accident prevention technology also provides alerts for different sensory organs, such as sight (LED around driver’s seat), touch (vibrating seat), hearing (headrest speaker), etc.

Hyundai Mobis plans to apply various biohealth technologies to public transportation in order to contribute to public safety. Mr. Brain will first conduct an application test on public buses in Gyeonggi-do.


Source link

Hyundai Mobis Unveils New In-Cabin Healthcare Technology To Analyze Brainwaves

[Courtesy of Hyundai Mobis]

SEOUL – Hyundai Mobis, a parts manufacturing unit of the South Korean automotive group Hyundai, has unveiled new in-cabin healthcare technology that can measure and analyze brain waves to check the condition of drivers. The technology should prevent accidents that can occur due to drowsy driving or sudden health problems.

New healthcare technology called “Mr. Brain” will be applied to public buses for evaluation. Hyundai Mobis would extend the demonstration of its new technology to commercial vehicles. “In addition to the safety and convenience of passengers that are necessary at the stage of fully autonomous driving, we have started to deliver results in the area of ​​digital healthcare,” said Lee Seung-hwan, head of the sector. Hyundai Mobis research, in a July 21 statement.

Mr. Brain uses atrium-type sensors to detect brain waves around the ears and determine the condition of conductors. machine learning interprets what brain wave signals mean. Connected to a smartphone app, Mr. Brain sends a warning when the driver’s attention is lost. Crash Reduction Technology alerts various sensory organs using LEDs around the driver’s seat, a vibrating seat, and a headrest speaker.

Biohealth technology will eventually evolve into a personalized in-cabin security service that integrates brain waves and other biological signals to understand passenger psychology, Hyundai Mobis said, adding that at the autonomous driving stage, various services health and entertainment for passengers would emerge. regardless of the recognition of the driving environment outside the vehicle.

Hyundai Mobis has accelerated the development of sensors, cameras and other parts for autonomous vehicles and infotainment for autonomous vehicles. In 2019, the company made a strategic investment in Beijing Deep Glint Technology, a Chinese startup known for facial recognition technology, to develop motion recognition and pattern analysis using deep learning. . Facial recognition is said to be used to prevent drowsiness while driving and to detect health problems.

In March 2020, Hyundai Mobis unveiled an interior safety alert system using radar sensors to prevent child deaths from heatstroke. The radar-based Rear Occupant Alert (ROA) system alerts the driver via the dashboard or smartphone if a passenger remains in the back seat. Hyundai Mobis would upgrade its system to measure the heart rate of passengers.

© Aju Business Daily & www.ajunews.com Copyright: Any material on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without permission of Aju News Corporation.


Source link

Africa: Recognizing advances in health technologies in Africa

Vanessa Obioha reports that Mary Akangbe, a renowned specialist practitioner in minimally invasive surgery and trained robotic assistant recently hosted the Africa Healthcare Awards and Summit in Lagos, where healthcare professionals from across Africa deliberated on technological advancements. carried out in the sector and called for more multisectoral collaboration.

Recently, Mary Akangbe, President and Founder of Zenith Global Health convened the Africa Healthcare Awards and Summit (AHAS). The two-day event that took place at the Oriental Hotel, Lagos and brought together top healthcare professionals from African countries online including South Africa, Mali, Zambia and Senegal.

For its first edition, the event looked at “advances in diabetes and cancer care” with speeches by Stanley Okolo, Director General of the West African Health Organization (WHO ) and the West African Healthcare Federation, Clare Omatseye, on the two days respectively. The two professionals underlined the importance of multisectoral collaboration within the health space.

Kebbi State First Lady Dr Zainab Shinkafi-Bagudu also spoke virtually at the event, which highlighted finances, infrastructure and resources as the main obstacles to cancer care. .

“Cancer is rapidly becoming the cause of premature death. More needs to be done to bridge the gap in cancer care between countries, economies and professions, ”she noted.

Likewise, Lagoon Hospitals CEO Dr Jimi Coker gave an overview of cancer care in Nigeria. Using statistical data, he found that there were 124,815 new cancer cases and over 78,000 deaths. Dr Mohamed El Sahili, CEO of Medland Healthcare Zambia, provided an overview of healthcare accessibility, who said that cultural biases play a role in mitigating this access to healthcare for patients.

Drug safety was a topic of discussion at the summit where one of the speakers, Dr Lolu Oju, noted that 70 percent of drugs manufactured are found outside Nigeria, with only one percent of human vaccines manufactured. This shows that the continent is lagging behind in vaccine production, especially at a time when developing countries grapple with accessibility to COVID-19 vaccines.

Akangbe is no stranger to healthcare technology. She is a practitioner specializing in minimally invasive surgery and a robotic assistant trained with an interest in AI, genomics and health technologies. As President of Zenith Global Health and Zenith Global Healthcare Professional Awards – a platform for healthcare professionals by healthcare professionals – she has been actively involved in the transformation of healthcare in Africa for over a decade.

The AHAS, she said, is an offshoot of the Zenith Global Health Awards, held in the UK for the past five years.

“We have received input from health professionals from all over Africa. In 2020 we have decided to have the African version of the Zenith Global Health Awards because we know that the impact of advances in healthcare across Africa cannot be underestimated. We have come a long way. far from where we are and healthcare professionals, organizations and stakeholders deserve recognition on the global platform. “


Source link

General Electric Company (NYSE: GE), (SOPH) – Health technology company Sophia Genetics files $ 100 million IPO and signs cancer data deal with GE Healthcare

  • According to a SEC registration statement, Sophia Genetics SA (NASDAQ: SOPH) is looking to raise $ 100 million in an initial public offering.
  • The company has not disclosed how many shares it will offer or the price range of the IPO.
  • With two headquarters in Saint-Sulpice, Switzerland, and Boston, the bioinformatics company will be listed on the NASDAQ under the symbol SOPH.
  • JP Morgan, Morgan Stanley, Cowen and Credit Suisse act as co-book managers for the offering.
  • To date, Sophia has raised at least $ 251 million in private equity, most recently in a $ 110 million Series F round that closed in October 2020.
  • The company offers a core genomic analysis platform called Data-Driven Medicine, a cloud-based SaaS platform to analyze data and generate information from multimodal datasets and different diagnostic modalities. .
  • The platform and associated solutions are currently used by more than 750 hospitals, laboratories and biopharmaceutical institutions around the world.
  • Sophia also announced that she signed a letter of intent with GE Healthcare Co-develop new analysis and workflow technologies based on artificial intelligence to improve the matching of treatments based on the genetic and tumor profiles of cancer patients.


Source link